{"favorite_id": 19, "calc_type": "", "dosing": false, "full_title_en": "Absolute Neutrophil Count (ANC)", "short_title_en": "Absolute Neutrophil Count", "medium_description_en": "Frequently used to assess neutropenic fever in chemotherapy patients.", "short_description_en": "Neutropenia (after chemotherapy).", "before_use": "", "instructions_en": "", "purpose_en": ["Calculation", "Diagnosis"], "disease_en": ["Cancer", "Chemotherapy"], "specialty_en": ["Critical Care", "Emergency Medicine", "Family Practice", "Hematology and Oncology", "Infectious Disease", "Internal Medicine", "Palliative Care/Hospice"], "chief_complaint_en": ["Fever"], "system_en": ["Hematologic", "Immunologic", "Oncologic"], "search_abbreviation_en": ["cancer", "fever", "chemo", "anc"], "slug": "absolute-neutrophil-count-anc", "seo": {"meta_description_en": "The Absolute Neutrophil Count (ANC) is frequently used to assess neutropenic fever in chemotherapy patients.", "keywords_en": "Absolute Neutrophil Count (ANC), anc, neutropenic fever, fever anc, anc calc, neutrophil count calc, absolute neutrophil, neutrophil, neutropenic fever, anc calc, anc score, AN count, neutrophil count, r/o cause of fever, WBC neutro, WBC neutrophil, WBC neutropenia, WBC bands, WBC PMN, Neutropenia ANC, Neutropenic ANC, Neutropenic fever ANC, Neutropenia calc, Neutropenia anc calc, Neutropenia absolute, Neutropenia number, neutrophil number, neutrophil #, neutrophil count, Filgrastim, Filgrastim calc, Filgrastim anc, Filgrastim neutro, Filgrastim neutrophil, Filgrastim neutropenia, G-CSF calc, G-CSF needed, G-CSF neutrophil count, G-CSF neutropenia, csf neutro, csf neutropenia, gcsf neutro, gcsf neutrophil, G-CSF neutrophil, cells / mm3, cells mm3, cells mm3 calc, cells mm3 score, cells mm3 neutro, wbc cells mm, wbc cells neutro, mm neutro calc, bands neutro, pmns neutro"}, "content": {"how_to_use": {"use_case_en": "<p>The ANC can be critical in assessing an immunocompromised patient\u2019s risk for developing opportunistic infections. It is commonly used in the hospital setting, clinic, and emergency department. If a patient undergoing active myelosuppressive chemotherapy presents with a sustained fever (with or without localizing symptoms), there is a risk of progression to sepsis. Thus, it is imperative to calculate the ANC to empiric antibiotics should be initiated. </p>", "pearls_pitfalls_en": "<ul> <li>The ANC calculation is not a static measurement done only once upon hospital admission. Rather, it is often measured daily in critically ill patients to assess the bone marrow\u2019s response after chemotherapy, for example.</li> <li>Recall that the ANC is dynamic - it is an absolute value and is <strong>expected</strong> to drop during the patient\u2019s nadir after chemotherapy.</li> </ul>", "why_use_en": "<p>The calculation can be completed with a routine complete blood count and differential. It is a tool to provide a rapid risk stratification. No additional laboratory work is needed to complete the calculation. </p> "}, "next_steps": {"advice_en": "<ul>\n<li>Neutropenic fever (without a source of infection found) is typically the result of direct toxic effects of chemotherapy on mucosal surfaces and the immune system in addition to the impact of the underlying malignancy. It is defined as a single oral temperature of 38.3&ordm;C (101&ordm;F) or a temperature of greater than 38.0&ordm;C (100.4&ordm;F) sustained for more than 1 hour in a patient with neutropenia. It is typically seen in those who have received anti-cancer therapies in the last 6 weeks. Filgrastim (Neupogen),&nbsp;a.k.a. G-CSF, can stimulate production of neutrophils, but is rarely indicated in the evaluation and treatment of neutropenic fever.</li>\n<li>Additional tools to risk stratify a neutropenic fever patient and predict complications include the <calculator id=\"3997\">Clinical Index of Stable Febrile Neutropenia (CISNE)</calculator> and <calculator id=\"3913\">Multinational Association for Supportive Care in Cancer (MASCC) Score</calculator>.</li>\n</ul>", "management_en": "<ul>\n<li>Obtain a complete blood count with differential.</li>\n<li>ANC is calculated as 10 x WBC count in 1000s x (% <abbr title=\"Polymorphonuclear neutrophils\">PMNs</abbr> + % bands).</li>\n<li>Classify neutropenia as mild, moderate, or severe as in <a href=\"#evidence\">Evidence</a>.</li>\n<li>ANC values can&nbsp;also&nbsp;be interpreted by NCI risk categories:</li>\n</ul>\n<div class=\"table-responsive\">\n<table class=\"table table-bordered table-hover\">\n<tbody>\n<tr>\n<th>NCI Risk Category</th>\n<th>ANC</th>\n</tr>\n<tr>\n<td>0</td>\n<td>Within normal limits</td>\n</tr>\n<tr>\n<td>1</td>\n<td>&ge;1,500 to &lt;2,000 cells/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td>2</td>\n<td>&ge;1,000 to &lt;1,500 cells/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td>3</td>\n<td>&ge;500 to &lt;1,000 cells/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td>4</td>\n<td>&lt;500 cells/mm<sup>3</sup></td>\n</tr>\n</tbody>\n</table>\n</div>", "critical_actions_en": "<p>If the clinical scenario is suggestive of neutropenic fever, appropriate cultures and infectious disease workup should be instituted along with prompt initiation of empiric broad-spectrum antibiotics to cover mostly endogenous flora.</p> "}, "about": {"formula_en": "<p>Absolute neutrophil count = 10 x WBC count x (%&nbsp;<abbr title=\"Polymorphonuclear neutrophils\">PMNs</abbr>&nbsp;+ % bands)</p>\n<p>Note: assumes WBC count in 1,000s (i.e., x 10&sup3; cells/&micro;L, also equivalent to x 10&sup3; cells/mm&sup3;).</p>\n<p>Example, normal patient:</p>\n<ul>\n<li>CBC shows WBC 9.2 (units are x 10&sup3; cells/&micro;L), 33% neutrophils, and 1% bands.</li>\n<li>ANC = 10 x 9.2 x (33 + 1)</li>\n<li>ANC = 10 x 9.2 x 34</li>\n<li>ANC = 3,128 cells/&micro;L &rarr; normal, no neutropenia</li>\n</ul>\n<p>Example, neutropenic patient:</p>\n<ul>\n<li>CBC shows WBC 1.0 (units are x 10&sup3; cells/&micro;L), 11% neutrophils, and 5% bands.</li>\n<li>ANC = 10 x&nbsp;1 x (11 + 5)</li>\n<li>ANC = 160 cells/&micro;L &rarr; severe neutropenia</li>\n</ul>\n<p></p>", "more_info_en": "<p>Neutropenia: ANC &lt;1,500 cells/mm<sup>3</sup></p>\n<ul>\n<li>Mild neutropenia: 1,000-1,500 cells/mm&sup3;</li>\n<li>Moderate neutropenia: 500-999 cells/mm&sup3;</li>\n<li>Severe neutropenia: &lt;500 cells/mm&sup3;</li>\n</ul>", "evidence_based_medicine_en": "<p><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17709921\" target=\"_blank\">A study</a> testing the application of ANC was done to predict bacterial infections. They examined 105 peripheral blood smears and along with the ANC, determined the sensitivity of predicting bacterial infections. ANC and toxic granulations are more sensitive than the band count in predicting bacterial infections. <a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314422/\" target=\"_blank\">A validation study</a> tested if the first-cycle nadir ANC predicted the risk of febrile neutropenia. This was a cross-validation study. An ANC of less than or equal to 0.5 x 10<sup>9</sup>/liter was associated with a relative odds ratio of 4.8. The goal of this study was to provide a foundation for which dose adjustments in chemotherapy can be made to provide maximal anti-neoplastic therapy while minimizing side effects.</p>", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/17709921", "text": "Al-Gwaiz LA, Babay HH. The diagnostic value of absolute neutrophil count, band count and morphologic changes of neutrophils in predicting bacterial infections. Med Princ Pract. 2007;16(5):344\u20137. doi:10.1159/000104806."}], "Other References": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/10944139/", "text": "Klastersky J, et. al. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000 Aug;18(16):3038-51."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/25559804", "text": "Carmona-Bayonas A, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of theClinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347. Epub 2015 Jan 5."}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197862/", "text": "Thomas BN, Karen MP, Soora W, David D, Gabriel JE. Interpreting Complete Blood Counts Soon After Birth in Newborns at Risk for Sepsis. Pediatrics 2010;126(5):903-909. doi:10.1542/peds.2010-0935."}, {"href": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314422/", "text": "Rivera E, Haim Erder M, Fridman M, Frye D, Hortobagyi GN. First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study. Breast Cancer Research\u202f: BCR. 2003;5(5):R114-R120."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Sagar Patel, MD, is currently a fellow in hematology and oncology at the Cleveland Clinic. A native of Minneapolis, he attended the University of Minnesota for both his medical school and internal medicine residency training. Dr. Patel\u2019s areas of interest include health informatics and its advancement of clinical care and research realms. His disease research interests include leukemias, lymphomas, plasma cell neoplasms, and bone marrow transplantation.</p>", "firstName": "Sagar", "img": "sagar-patel.jpg", "lastName": "Patel", "name": "Sagar Patel, MD", "target": "sagar-patel", "signedCOI": true, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Layla A. Al-Gwaiz", "qa_en": "", "approved": false, "creator_info": {"about_en": "<p>Layla A. Al-Gwaiz, MD, FCAP is a practicing physician and researcher in Hematology Section of the Department of Pathology at King Khalid University Hospital in Riyadh, Kingdom of Saudi Arabia.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/default.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed?term=Al-Gwaiz%20LA%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [{"id": 62, "order": 0, "society": "EB Medicine", "link": "https://www.ebmedicine.net/topics/hematology-oncology/oncologic-ED-presentations", "text": "Calculated Decisions: ANC", "description": "Emergency Medicine Practice", "CalculatorId": 19, "createdAt": "2019-11-04T16:58:27.315Z", "updatedAt": "2019-11-13T02:33:59.865Z"}], "sdm_tool": []}}, "input_schema": [{"label_en": "% neutrophils", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "neutrophils", "unit": "neut", "type": "textbox", "unit_info": {"name": "% Neutrophils", "conversion": 1, "error_min": -0.01, "error_max": 100.01, "warn_min": 0, "warn_max": 100, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "%", "units_us": "%"}}, {"label_en": "% bands", "conditionality": "", "default": null, "tips_en": "", "optional": false, "name": "bands", "unit": "band", "type": "textbox", "unit_info": {"name": "% Bands", "conversion": 1, "error_min": -0.01, "error_max": 100.01, "warn_min": 0, "warn_max": 30, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "%", "units_us": "%"}}, {"label_en": "<abbr title='White blood cell'>WBC</abbr> count", "conditionality": "", "default": null, "tips_en": "Per 1000. Enter as 8.4, not 8400", "optional": false, "name": "white_blood_cell_count", "unit": "wbc", "type": "textbox", "unit_info": {"name": "White Blood Cell Count", "conversion": 1, "error_min": 0.0001, "error_max": 500, "warn_min": 0.1, "warn_max": 100, "normal_max_si": 10.7, "normal_min_si": 3.7, "normal_min_us": 3.7, "units_si": "\u00d7 10\u2079 cells/L", "units_us": "\u00d7 10\u00b3 cells/\u00b5L", "normal_max_us": 10.7}}], "md5": "", "cmeVersion": "19.1", "related_calcs": [{"calcId": 3913, "short_title_en": "MASCC Risk Index", "slug": "mascc-risk-index-for-febrile-neutropenia"}, {"calcId": 3997, "short_title_en": "CISNE", "slug": "clinical-index-stable-febrile-neutropenia-cisne"}, {"calcId": 3315, "short_title_en": "Khorana Risk Score for VTE", "slug": "khorana-risk-score-venous-thromboembolism-cancer-patients"}]}